Astrazeneca Share News (AZN)

TOP NEWS: AstraZeneca's Fasenra fails to meet trial's primary endpoint

(Alliance News) - AstraZeneca PLC on Tuesday said that its Fasenra treatment failed to meet one of its two primary endpoints in its Messina Phase 3 trial in eosinophilic esophagitis.

AstraZeneca says Fasenra fails to meet one trial endpoint

(Sharecast News) - AstraZeneca said its Fasenra treatment for a rare inflammatory disease of the oesophagus failed to meet one of the two dual-primary endpoints in a phase 3 trial.

AstraZeneca treatment gets FDA approval for US liver cancer patients

(Alliance News) - AstraZeneca PLC on Monday said one of its treatments has been approved in the US for treating adults with unresectable liver cancer.

AstraZenenca liver cancer combination treatment approved by FDA

(Sharecast News) - AstraZeneca said its Imjudo drug, in combination with Imfinzi, hadbeen approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer, the company said on Monday.

UK stocks end volatile session higher after Prime Minister Liz Truss resigns

Liz Truss to quit as UK prime minister next week

*

TOP NEWS: AstraZeneca says Evusheld shows promise on Covid variants

(Alliance News) - AstraZeneca PLC on Thursday said that new analyses from a phase 3 treatment trial show the potential of its Covid drug Evusheld to reduce severity and mortality.

LONDON BROKER RATINGS: HSBC lifts Marston's; Barclays cuts Flutter

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

LONDON MARKET CLOSE: Stocks down as BoE confirms end to bond-buying

(Alliance News) - Stock prices in London closed in the red on Wednesday, as discouraging economic data and mixed signals from the UK's central bank weighed on investor sentiment.

AstraZeneca to show 'exceptional' data on neuromyelitis drug Ultomiris

(Alliance News) - AstraZeneca PLC on Wednesday said its subsidiary Alexion Pharmaceuticals Inc, which focuses on rare diseases, will publish "new data showing significant advances" regarding the treatment for a form of neuromyelitis with its drug Ultomiris.

Illumina collaborates with AstraZeneca on AI-focused research

(Alliance News) - Illumina Inc on Tuesday said it is collaborating with AstraZeneca PLC on drug target discovery, with a focus on artificial intelligence-based research on genes.

Mexico pursuing EU deal to locally produce vaccines, meds

MEXICO CITY, Oct 11 (Reuters) - Mexico could soon close a contract for European pharmaceutical companies to produce vaccines and medicines in Mexico, a senior official told Reuters, as the Latin American country aims to be better prepared for future health crises.

U.S. adds China's YMTC and 30 other firms to 'unverified' trade list

WASHINGTON, Oct 7 (Reuters) - The United States on Friday added China's top memory chipmaker YMTC and 30 other Chinese entities to a list of companies that U.S. officials have been unable to inspect, ratcheting up tensions with Beijing and starting a 60 day-clock that could trigger much tougher penalties.

U.S. aims to hobble China's chip industry with sweeping new export rules

Oct 7 (Reuters) - The Biden administration on Friday published a sweeping set of export controls, including a measure to cut China off from certain semiconductor chips made anywhere in the world with U.S. tools, vastly expanding its reach in its bid to slow Beijing's technological and military advances.

Oddo BHF flags European pharma's attractive growth profile, prefers Novo Nordisk, AstraZeneca

LONDON BROKER RATINGS: GSK raised to 'outperform'; RBC cuts THG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: